Table 1_Gastrointestinal symptoms and the Mediterranean dietary pattern: secondary analysi

200 participants with increased cardiometabolic risk were enrolled in a 12-week trial of a New Zealand-adapted Mediterranean diet. The secondary analysis data likely contains scores from the Gastrointestinal Symptom Rating Scale and the 36-Item Short-Form Survey, assessing quality of life. Ella Silk authored this dataset, which was last updated in April 2026.

Use Cases

• Analyzing the relationship between dietary intervention and gastrointestinal symptom severity based on GSRS domain scores.
• Investigating demographic influences on baseline GI symptoms based on participant characteristics like gender and ethnicity.
• Modeling correlations between gastrointestinal health and quality-of-life measures based on SF-36 survey data.

Strengths

• Data originates from a randomized controlled trial, a robust study design.
• Includes results for 200 participants with a mean age of 49.9 years and 62% women.
• Clinical trial identifiers (ACTRN12622000906752, ISRCTN89011056) are provided for verification.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is small at 693.6 KB, indicating limited scope.

Provenance

Source

Secondary analysis of a randomized controlled trial.

Collection Method

Data collected from a 12-week dietary and behavioral intervention trial.

Time Range

The trial duration was 12 weeks; specific dates are not provided.

Freshness

Last updated 2026-04-20 04:13:20; freshness should be verified.

Geography

Study conducted in New Zealand, with participants including Māori and New Zealand Europeans.